×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Brain Cancer

Feature Video
Watch a video about Steve, an Optune user. Learn how Steve manages his treatment while enjoying his favorite activities.
Alexandra Guadagno
After two years, the Biden Cancer Initiative has shuttered as former Vice President Joe Biden’s presidential campaign begins in earnest.
Kristie L. Kahl
Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.
Kristie L. Kahl
A glioblastoma (GBM)-specific app, called OurBrainBank, efficiently collected patients’ symptoms – offering many hope for future research, according to founder Jessica Morris.
Alexandra Guadagno
The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.
Lori Luedtke
Don’t let a terminal diagnosis get you down to the point where you stop living your life. Have an adventure, buy the shoes and eat the cake.
Lori Luedtke
This cancer living inside of me has been life altering. On the outside you may think that things are not so bad. What you are not seeing is that my cancer is incurable.
Jeanine Gordon and Jaclyn Andronico
This essay was written by her colleagues, Jeanine Gordon and Jaclyn Andronico, Memorial Sloan Kettering Cancer Center, nominating Lisa Klempner, M.S.N., RN, OCN for CURE®’s 2019 Extraordinary Healer® Award.
Alexandra Guadagno
From the 9/11 Victim Compensation Fund to the untimely passing of an inspirational Olympic runner, here’s what is making headlines in the cancer space this week.
Aly Fox, B.S.N., RN, CMSRN
Amy Setesak, B.S.N., RN, CMSRN from Memorial Sloan Kettering Cancer Center, New York, was nominated by her colleague, Aly Fox, B.S.N., RN, CMSRN, for CURE®’s Extraordinary Healer® Award.
Lori Luedtke
Four out of 100. That is the survival rate for stage 4 glioblastoma: four percent. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other